According to the report of "The Developments and Trends of China's Medical Device Industry" released by Roland Berger, a world leading management consultancy, the Chinese medical device market exceeded 900 billion yuan in 2022. It is projected to exceed 2.2 trillion CNY (about 320 billion USD) by 2030, making China potentially the largest medical device market globally.

On May 8, Singlera Genomics announced that its self-developed PDACatch test, a novel DNA methylation-based liquid biopsy test for detecting pancreatic cancer in high-risk populations, has been granted Breakthrough Medical Device designation by FDA.

On April 14, DiaSorin announced that Mr Tony Chan is the President of DiaSorin China. He will also serve as the Chairman of the Board of Directors of DiaSorin China.

The US Food and Drug Administration this week released its guidance document for developers of medical devices for COVID-19, including diagnostic tests, on how to transition from Emergency Use Authorization to full marketing and regulatory authorization.

On March 28, Sinopharm (Shanghai) Medical Device Supply Chain Co., Ltd. and Calibra signed a strategic cooperation agreement in Hangzhou, China.

Recently, executives from multinational medical enterprises intensively visited China or revealed their plans to visit China. It is becoming a common question for most multinational medical businesses to explore how to support China's high-level opening up.

Becton Dickinson announced on Tuesday a collaboration with Magnolia Medical Technologies, under which the firms will co-sell and comarket the Magnolia Medical Steripath and Steripath Micro Initial Specimen Diversion Device, which complement the BD Vacutainer specimen collection portfolio.

Johnson & Johnson Medical Devices has rebranded as Johnson & Johnson MedTech as the unit moves deeper into digital technology.

On January 29, Shenzhen Tisenc Medical Devices Co., Ltd. underwent an industrial and commercial change. All the original shareholders withdrew, and WONDFO BIOTECH (300482) was newly added, holding 100% of the shares.

In case you missed it, the Medical Device Regulations in Canada quietly got updated in December 2020. The new regulation intends to boost post-market safety and requires manufacturers to submit a summary report.